Daiwa Securities Group Inc. Boosts Stock Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Daiwa Securities Group Inc. boosted its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 8.2% during the 3rd quarter, Holdings Channel.com reports. The firm owned 78,188 shares of the real estate investment trust’s stock after purchasing an additional 5,921 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Sabra Health Care REIT were worth $1,455,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of SBRA. Point72 Asset Management L.P. increased its holdings in Sabra Health Care REIT by 152.7% during the 2nd quarter. Point72 Asset Management L.P. now owns 1,732,274 shares of the real estate investment trust’s stock worth $26,677,000 after purchasing an additional 1,046,748 shares during the last quarter. Thrivent Financial for Lutherans increased its holdings in Sabra Health Care REIT by 1,557.9% during the 3rd quarter. Thrivent Financial for Lutherans now owns 927,309 shares of the real estate investment trust’s stock worth $17,258,000 after purchasing an additional 871,375 shares during the last quarter. Millennium Management LLC purchased a new stake in Sabra Health Care REIT during the 2nd quarter worth approximately $12,972,000. APG Asset Management US Inc. increased its holdings in Sabra Health Care REIT by 28.9% during the 2nd quarter. APG Asset Management US Inc. now owns 2,562,962 shares of the real estate investment trust’s stock worth $39,495,000 after purchasing an additional 575,000 shares during the last quarter. Finally, Renaissance Technologies LLC increased its holdings in shares of Sabra Health Care REIT by 77.0% in the 2nd quarter. Renaissance Technologies LLC now owns 1,287,279 shares of the real estate investment trust’s stock valued at $19,824,000 after acquiring an additional 559,800 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Health Care REIT Trading Up 0.4 %

NASDAQ:SBRA opened at $18.91 on Friday. Sabra Health Care REIT, Inc. has a 12-month low of $12.83 and a 12-month high of $20.03. The firm has a market capitalization of $4.47 billion, a P/E ratio of 46.12, a P/E/G ratio of 2.33 and a beta of 1.25. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16. The business has a 50 day simple moving average of $18.63 and a 200 day simple moving average of $16.78.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.22). Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. The company had revenue of $178.00 million for the quarter, compared to analyst estimates of $177.19 million. During the same quarter in the prior year, the firm earned $0.34 EPS. Equities research analysts predict that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Shareholders of record on Friday, November 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.35%. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 292.69%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on SBRA shares. Wells Fargo & Company upgraded Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $16.00 to $20.00 in a report on Tuesday, October 1st. Citigroup upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and boosted their price target for the company from $17.00 to $20.00 in a report on Friday, September 13th. Truist Financial boosted their price target on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Finally, Scotiabank boosted their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a report on Friday, October 11th. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, Sabra Health Care REIT presently has an average rating of “Moderate Buy” and a consensus target price of $18.71.

Sabra Health Care REIT Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.